Accelerated Target to Lead Optimization platform using applied Artificial Intelligence. The platform offers small and large molecule capabilities, libraries and more. Significant Advantages over Schrodinger.

Ainnocence created a fast and self-evolving artificial intelligence platform to simplify drug discovery and development. Ainnocence’s platform integrates multiple advanced computational and wet lab technologies to accelerate the discovery and development process for both small molecule and biologics therapies.

Ainnocence’s cloud based software suite screens billions of chemical compounds and biological molecules in minutes, integrates binding prediction, off-target toxicity, and a full pharmacological profile AI evaluation into a single work flow, and simplifies and de-risks multiple steps in the discovery and development process.

Ainnocence’s advanced deep learning engine is constantly validated by industrial experts, and undergoes reinforcement learning cycles and automatic ETL processes. The platform is currently offers small molecule, biologics and other new modalities’ design services and pipeline collaborations.